Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology. 2013 May; 144(5):1098-106.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.